MAPE; OIP4; CT130; Cancer/Testis Antigen 130; Opa-interacting protein 4; Melanoma antigen preferentially expressed in tumors
Name Synonym
Preferentially Expressed Antigen In Melanoma
Uniprot
P78395
Field of Research
Tumor immunity
Applications
WB
Organism Species
Homo sapiens (Human)
Reactivity
Ra
Concentration
0.5mg/mL
Buffer
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Host
Rabbit
Host or Source
Rabbit
Source
Polyclonal antibody preparation
Immunogen
RPH323Hu02-Recombinant Preferentially Expressed Antigen In Melanoma (PRAME)
Recommended Usage
Western blotting: 0.01-2μg/mL; < br/> Immunohistochemistry: 5-20μg/mL; < br/> Immunocytochemistry: 5-20μg/mL; < br/> Optimal working dilutions must be determined by end user.
